Recombinant modified vaccinia virus Ankara (MVA) – based vaccine against H5N1 infection
The vaccine can be used against H5N1 infection for pre-pandemic use and for prophylactic and/or therapeutic vaccination. Furthermore a treatment of the avian flu in humans as well as other animals is possible.
Weitere Informationen: PDF
ipal GmbH
Tel.: +49 (0)30/2125-4820
Ansprechpartner
Ursula Haufe
